The Learned Intermediary Doctrine
The Doctrine
The Learned Intermediary Doctrine provides that a drug or medical device manufacturer has no legal duty to warn consumers of a drug or medical device’s harmful side effects if that information has been communicated to a “learned intermediary.”
Learned Intermediaries
The best example of a learned intermediary is a patient’s personal physician. The physician’s specialized medical training enables him or her to interpret the warnings provided by the manufacturer. As the intermediary between the manufacturer and the patient, the physician is best situated to decide whether the warnings apply to the patient, given the patient’s symptoms and condition. Should the drug or medical device cause the patient subsequent injury, as the learned intermediary, the prescribing physician could face legal liability for failing to warn the patient of harmful side effects (provided that the physician was adequately warned by the manufacturer).
Warnings
Generally, manufacturers provide warnings to learned intermediaries via the inserts in the packaging of a drug or medical device. In developing these warnings, manufacturers must consider any regulatory guidelines from the Food and Drug Administration or similar agency. Further, from a practical standpoint, the warning should:
- Indicate the scope of the danger;
- Convey the seriousness of the danger;
- Inform a reasonably prudent intermediary of the danger; and
- Communicate (or be presented) in a manner that is understandable to the intermediary.
A manufacturer’s duty to warn extends only to those harmful effects that the manufacturer is aware of or has reason to know. Manufacturers have a continuing obligation to ensure warnings are updated based on new information or research.
Although manufacturers should make every effort to keep their warnings up-to-date, failure to do so does not necessarily eliminate the protections afforded by the Doctrine. For example, if the learned intermediary became aware of a drug or medical device’s harmful side effects from sources other than the manufacturer, the Doctrine may still apply.
Doctrine Exceptions
Perhaps the most notable exception to the Doctrine concerns mass immunizations, such as flu vaccines, etc. While the manufacturer communicates the required warnings to the learned intermediary, the learned intermediary may not be present when the patient is inoculated. This means that the learned intermediary cannot assess the patient’s physical conditions, discuss any symptoms, or provide any warning information. In these instances, the manufacturer must ensure that the warnings are provided to the patient directly or require the entity giving the inoculation to provide the information to the patient at the time of inoculation.
How Medmarc Can Help
Life sciences and medical technology companies face complex and evolving risks throughout the product lifecycle. Medmarc provides specialized life sciences insurance, medical device insurance, products liability coverage, and risk management expertise to address the unique exposures of the industry. From emerging technologies and clinical trials to products on the market, Medmarc combines decades of life sciences experience with specialized industry knowledge and insurance solutions.
Explore Medmarc's insurance solutions to learn more about our capabilities, and talk with your insurance broker about your organization’s evolving risks and insurance considerations.
Phone: 888-633-6272
Copyright © 2026 - Medmarc
Medmarc is a proud member of TDC Specialty. TDC Specialty is the marketing name for the specialty insurance operations and services of The Doctors Company and its subsidiaries and affiliated companies, including TDC Specialty Underwriters, Inc., TDC Specialty Insurance Company, TDC National Assurance Company, Healthcare Risk Advisors, Inc., Hospitals Insurance Company, Inc., ProAssurance Specialty Insurance Company, NORCAL Specialty Insurance Company, and Medmarc Casualty Insurance Company. All products and services are written or provided by subsidiaries or affiliates of The Doctors Company. The Doctors Company does not underwrite excess and surplus lines insurance. Certain coverages may be provided through surplus lines insurance subsidiaries of The Doctors Company through licensed surplus lines brokers. Coverages may be underwritten by TDC Specialty Insurance Company, TDC National Assurance Company, Hospitals Insurance Company, Inc., ProAssurance Specialty Insurance Company, NORCAL Specialty Insurance Company, or Medmarc Casualty Insurance Company. Product summaries are for informational purposes only. Coverage is subject to the language of the policy as actually issued. Coverage, policy terms, and availability may vary by state.
TDC Specialty Underwriters, Inc., is based and domiciled in Connecticut; in California d/b/a Insurance City Solutions (license #0L85833) and in New York, d/b/a TDC Specialty Underwriters Services. Healthcare Risk Advisors, Inc., is based and domiciled in New York.
